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Social Science and the Study of
Emerging Infectious Diseases
Topics related to emerging and reemerging in-
fectious diseases attracted a considerable audi-
ence at the annual meeting of the American
Anthropological Association, November 15–19,
1995, in Washington, D.C. The meeting had a
separate session entitled “Emerging and Ree-
merging Infectious Diseases: Biocultural and So-
ciocultural Approaches.”
The session brought together anthropologists
interested in and working on emerging infectious
diseases from various subdisciplinary perspec-
tives. Presentations were made on the following
subjects: outline of a research agenda, deforesta-
tion and the emergence of infectious diseases in
the rain forests of Papua-New Guinea, the cholera
epidemic in Latin America, evolutionary aspects
of emergent infections, societal impacts of the test
for acquired immunodeficiency syndrome, compli-
ance and iatrogenesis in tuberculosis treatment in
the United States, patchwork policies that affect
long-term treatment of tuberculosis in Nepal and
Uganda, the reemergence of schistosomiasis in
Egypt, dengue control in Latin America, cultural
and political ecologic models of emergent infec-
tions, and the politics of leprosy eradication. Ab-
stracts are available from the conference
organizers, listed below.
Anthropologists interested in international
health and the social science aspects of infectious
diseases are organized in a working group called
the International Health and Infectious Disease
Study Group of the Society of Medical Anthropol-
ogy (American Anthropological Association). Re-
quests to subscribe to this group’s newsletter can
be sent to
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WHO Establishes New
Rapid-Response Unit for Emerging
Infectious Diseases
The World Health Organization (WHO) has
established a new rapid-response unit to control
and prevent the growing incidence of new and
reemerging diseases worldwide. The unit’s focus
will be improved containment of disease out-
breaks, such as that caused by the deadly Ebola
virus, which struck Zaire in 1995.
The WHO unit will be called the Division of
Emerging Viral and Bacterial Diseases Surveil-
lance and Control (EMC). It will be capable of
mobilizing staff from WHO headquarters in Ge-
neva and from the organization’s regional offices.
In addition to mobilizing WHO’s own technical
staff and expertise, EMC will coordinate the ac-
tivities of the agency’s traditional partners, for
example, its international network of collaborat-
ing centers, bilateral donors, expert advisers, and
nongovernmental organizations.
Teams equipped to implement epidemic control
measures will be placed on-site within 24 hours’
notification of an outbreak. This strategy, when
implemented in Zaire, not only rapidly contained
the recent Ebola outbreak but also prevented its
spread to Kinshasa, the capital city of 2 million.
Among EMC’s goals are 1) to strengthen local
surveillance and disease control so that countries
can develop the early warning systems needed to
detect emerging or reemerging diseases through
innovative field epidemiology and public health
laboratory training programs and 2) to continue
WHO’s activities in developing a network of public
health laboratories to strengthen regional and
international collaboration in outbreak detection
and control.
EMC will continue to expand WHO’s network—
termed WHONET—that detects and monitors an-
tibiotic resistance worldwide. WHO will use the
information collected to continue to advocate
research and development of new antibiotics to
replace those that are no longer effective.
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